Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-24 @ 2:31 PM
NCT ID:
NCT02389959
Eligibility Criteria:
Inclusion Criteria:
1. The patient carries a diagnosis of hereditary hemorrhagic telangiectasia (HHT)
2. The patient is to undergo treatment with electrocautery in the operating room under endoscopic visualization
3. The patient is able to give informed consent
4. The patient is at least 18 years old
Exclusion Criteria:
1. The patient has had prior treatment with systemic or nasal bevacizumab within the past year
2. The patient has undergone electrocautery for epistaxis within the 6 months prior to study enrollment
3. The patient is a minor
4. The patient is pregnant
5. The patient is incapable of understanding the consent process
6. The patient has a history of HIV or another known cause of immunosuppression, or is actively taking immunosuppressive medications due to organ transplantation, rheumatoid disease, or other medical conditions.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02389959
Study Brief:
Protocol Section:
NCT02389959